✦ LIBER ✦

O58 RESULTS FROM THE PHASE 2 PEARL-I STUDY: INTERFERON-FREE REGIMENS OF ABT-450/R + ABT-267 WITH OR WITHOUT RIBAVIRIN IN PATIENTS WITH HCV GENOTYPE 4 INFECTION

✍ Scribed by Hezode, C.; Marcellin, P.; Pol, S.; Hassanein, T.; Fleischer-Stepniewska, K.; Baykal, T.; Wang, T.; Lovell, S.S.; Pilot-Matias, T.; Vilchez, R.A.

Book ID: 122278757
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 64 KB
Volume: 60
Category: Article
ISSN: 0168-8278
DOI: 10.1016/S0168-8278(14)60060-X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

O114 RESULTS OF THE PHASE 2 STUDY M12-99

O114 RESULTS OF THE PHASE 2 STUDY M12-999: INTERFERON-FREE REGIMEN OF ABT-450/R/ABT-267 + ABT-333 + RIBAVIRIN IN LIVER TRANSPLANT RECIPIENTS WITH RECURRENT HCV GENOTYPE 1 INFECTION

✍ Kwo, P.; Mantry, P.; Coakley, E.; Te, H.; Vargas, H.; Brown, R.; Gordon, F.; Lev 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 63 KB

3 SAFETY AND EFFICACY OF INTERFERON-FREE

3 SAFETY AND EFFICACY OF INTERFERON-FREE REGIMENS OF ABT-450/r, ABT-267, ABT-333 +/− RIBAVIRIN IN PATIENTS WITH CHRONIC HCV GT1 INFECTION: RESULTS FROM THE AVIATOR STUDY

✍ Kowdley, K.V.; Lawitz, E.; Poordad, F.; Cohen, D.E.; Nelson, D.; Zeuzem, S.; Eve 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 376 KB

929e PEARL-II: Randomized Phase 3 Trial

929e PEARL-II: Randomized Phase 3 Trial of Interferon-Free, 12-Week Regimen of ABT-450/r/ABT-267, ABT-333 With or Without Ribavirin in Hepatitis C Virus Genotype 1b-Infected, Treatment-Experienced Patients

✍ Andreone, Pietro; Colombo, Massimo; Enejosa, Jeffrey V.; Koksal, Iftihar; Ferenc 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 50 KB

O60 SAPPHIRE I: PHASE 3 PLACEBO-CONTROLL

O60 SAPPHIRE I: PHASE 3 PLACEBO-CONTROLLED STUDY OF INTERFERON-FREE, 12-WEEK REGIMEN OF ABT-450/R/ABT-267, ABT-333, AND RIBAVIRIN IN 631 TREATMENT-NAIVE ADULTS WITH HEPATITIS C VIRUS GENOTYPE 1

✍ Feld, J.J.; Kowdley, K.V.; Coakley, E.; Sigal, S.; Nelson, D.; Crawford, D.; Wei 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 64 KB

514 Interferon-Free Regimens of Abt-450/

514 Interferon-Free Regimens of Abt-450/R, Abt-267, Abt-333, and Ribavirin Achieve High Sustained Virologic Response 4 Weeks Post-Treatment (SVR4) Rates in Patients With Chronic HCV Genotype 1 Regardless of Race, Ethnicity, or Other Baseline Characteristics

✍ Rodriguez-Torres, Maribel; Nunes, Frederick; Cohen, Daniel; Xie, Wangang; Marinc 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 376 KB